Advent Pharma Ltd. (DSE:ADVENT)
13.40
+0.20 (1.52%)
At close: Jun 4, 2025
Advent Pharma Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
Cash & Equivalents | 3.61 | 3.97 | 1.07 | 4.31 | 2.69 | 6.34 | Upgrade
|
Short-Term Investments | - | - | - | - | 40 | 40 | Upgrade
|
Cash & Short-Term Investments | 3.61 | 3.97 | 1.07 | 4.31 | 42.69 | 46.34 | Upgrade
|
Cash Growth | -16.52% | 269.51% | -75.11% | -89.89% | -7.88% | -47.78% | Upgrade
|
Receivables | 169.25 | 142.81 | 126.49 | 116.17 | 114.02 | 118.24 | Upgrade
|
Inventory | 73.32 | 67.24 | 79.75 | 81.33 | 75.41 | 68.04 | Upgrade
|
Prepaid Expenses | - | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | Upgrade
|
Other Current Assets | 28.14 | 28.01 | 29.83 | 32.72 | 29.81 | 33.57 | Upgrade
|
Total Current Assets | 274.31 | 242.08 | 237.2 | 234.59 | 261.98 | 266.23 | Upgrade
|
Property, Plant & Equipment | 1,631 | 1,615 | 1,551 | 1,409 | 1,258 | 1,106 | Upgrade
|
Total Assets | 1,906 | 1,857 | 1,788 | 1,644 | 1,520 | 1,372 | Upgrade
|
Accounts Payable | 9.92 | 9.64 | 20.6 | 10.42 | 8.92 | 9.27 | Upgrade
|
Accrued Expenses | 45.18 | 43.87 | 61.51 | 48.74 | 38.96 | 27.44 | Upgrade
|
Short-Term Debt | 59.01 | 60 | 54.99 | 43.27 | 36.83 | 23.36 | Upgrade
|
Current Portion of Long-Term Debt | 7.91 | 7.91 | 7.91 | 7.91 | 7.91 | 7.91 | Upgrade
|
Current Portion of Leases | 0.17 | 0.67 | 0.76 | 0.64 | 0.61 | 0.65 | Upgrade
|
Current Income Taxes Payable | 57.81 | 54.69 | 53.3 | 55.6 | 52.41 | 49.37 | Upgrade
|
Other Current Liabilities | 3.96 | 12.1 | 7.24 | 2.99 | 6.67 | 14.75 | Upgrade
|
Total Current Liabilities | 183.97 | 188.88 | 206.32 | 169.57 | 152.31 | 132.75 | Upgrade
|
Long-Term Debt | 7.43 | 7.43 | 7.43 | 11.02 | 14.56 | 16.52 | Upgrade
|
Long-Term Leases | - | - | 0.49 | 1.08 | - | 0.49 | Upgrade
|
Long-Term Deferred Tax Liabilities | 201.59 | 190.41 | 175.2 | 148.56 | 118.99 | 101.43 | Upgrade
|
Total Liabilities | 392.99 | 386.72 | 389.44 | 330.23 | 285.86 | 251.19 | Upgrade
|
Common Stock | 931.33 | 931.33 | 931.33 | 931.33 | 913.07 | 830.06 | Upgrade
|
Retained Earnings | 581.42 | 538.68 | 467.73 | 382.12 | 321.11 | 290.53 | Upgrade
|
Shareholders' Equity | 1,513 | 1,470 | 1,399 | 1,313 | 1,234 | 1,121 | Upgrade
|
Total Liabilities & Equity | 1,906 | 1,857 | 1,788 | 1,644 | 1,520 | 1,372 | Upgrade
|
Total Debt | 74.52 | 76.01 | 71.59 | 63.92 | 59.91 | 48.93 | Upgrade
|
Net Cash (Debt) | -70.91 | -72.04 | -70.52 | -59.61 | -17.22 | -2.59 | Upgrade
|
Net Cash Per Share | -0.76 | -0.77 | -0.76 | -0.64 | -0.18 | -0.03 | Upgrade
|
Filing Date Shares Outstanding | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | Upgrade
|
Total Common Shares Outstanding | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | 93.13 | Upgrade
|
Working Capital | 90.34 | 53.2 | 30.88 | 65.02 | 109.67 | 133.48 | Upgrade
|
Book Value Per Share | 16.24 | 15.78 | 15.02 | 14.10 | 13.25 | 12.03 | Upgrade
|
Tangible Book Value | 1,513 | 1,470 | 1,399 | 1,313 | 1,234 | 1,121 | Upgrade
|
Tangible Book Value Per Share | 16.24 | 15.78 | 15.02 | 14.10 | 13.25 | 12.03 | Upgrade
|
Land | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
Buildings | 1,245 | 1,245 | 1,245 | 1,123 | 925.16 | 758.84 | Upgrade
|
Machinery | 570.15 | 530.34 | 527.92 | 458.43 | 442.57 | 442.28 | Upgrade
|
Construction In Progress | 148.77 | 124.58 | 15.86 | 7.39 | 29.72 | 5.92 | Upgrade
|
Updated Nov 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.